Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 33,00 € Taxes included to order
    Pages Iconography Videos Other
    2 1 0 0


Joint Bone Spine
Volume 80, n° 6
pages 670-671 (décembre 2013)
Doi : 10.1016/j.jbspin.2013.03.009
accepted : 26 February 2013
Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis
 

Daniel Wendling a, , Claire Vidon a, Marie Godfrin-Valnet a, Gilles Rival b, Xavier Guillot a, Clément Prati a
a Service de rhumatologie, CHRU de Besançon, boulevard Fleming, 25030 Besançon, France 
b Service de pneumologie, CHRU de Besançon, boulevard Fleming, 25030 Besançon, France 

Corresponding author.

Keywords : Pulmonary fibrosis, Interstitial lung disease, Rheumatoid arthritis, Tocilizumab




© 2013  Société française de rhumatologie@@#104156@@